Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kevin B Kaiserman"'
Publikováno v:
Diabetes Therapy. 14:611-617
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7507e7853fcf67f04e281897d4784f44
https://doi.org/10.1007/s13300-023-01368-7
https://doi.org/10.1007/s13300-023-01368-7
Autor:
Satish K, Garg, George, Grunberger, Ruth, Weinstock, Margaret L, Lawson, Irl B, Hirsch, Linda A, DiMeglio, Rodica, Pop-Busui, Athena, Philis-Tsimikas, Mark, Kipnes, David R, Liljenquist, Ronald L, Brazg, Yogish C, Kudva, Bruce A, Buckingham, Janet B, McGill, Anders L, Carlson, Amy B, Criego, Mark P, Christiansen, Kevin B, Kaiserman, Kurt J, Griffin, Greg P, Forlenza, Bruce W, Bode, Robert H, Slover, Ashleigh, Keiter, Chenxiao, Ling, Briggitte, Marinos, Toni L, Cordero, John, Shin, Scott W, Lee, Andrew S, Rhinehart, Robert A, Vigersky, Mary, Jane Clifton
Publikováno v:
Diabetes Technology & Therapeutics. 25:1-12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df0713dbe8c9a3f158f7243c139fea68
https://doi.org/10.1089/dia.2022.0421
https://doi.org/10.1089/dia.2022.0421
Autor:
Ron Brazg, Satish K. Garg, Anuj Bhargava, James R. Thrasher, Kashif Latif, Bruce W. Bode, Timothy S. Bailey, Barry S. Horowitz, Arvind Cavale, Yogish C. Kudva, Kevin B. Kaiserman, George Grunberger, John Chip Reed, Sarnath Chattaraj, Gina Zhang, John Shin, Vivian Chen, Scott W. Lee, Toni L. Cordero, Andrew S. Rhinehart, Robert A. Vigersky, Bruce A. Buckingham
Publikováno v:
Diabetes Technology & Therapeutics. 24:535-543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d493aa6d945bb577624a173de2c28f6b
https://doi.org/10.1089/dia.2021.0540
https://doi.org/10.1089/dia.2021.0540
Autor:
Richard A.M. Jonkers, Robert A. Vigersky, John H. Shin, Toni L. Cordero, Anirban Roy, Dorothy I. Shulman, Rodica Pop-Busui, Melissa Vella, Athena Philis-Tsimikas, Mark Kipnes, Benyamin Grosman, John C. Reed, Xiaoxiao Chen, Andrew S. Rhinehart, Kevin B. Kaiserman, Mark P. Christiansen, Anders L. Carlson, James Thrasher, Bruce W. Bode, Robert H. Slover, Jennifer L. Sherr, Scott W. Lee, Ron Brazg, Satish K. Garg, David R. Lilenquist
Publikováno v:
Diabetes Technology & Therapeutics. 24:178-189
Introduction: This trial assessed safety and effectiveness of an advanced hybrid closed-loop (AHCL) system with automated basal (Auto Basal) and automated bolus correction (Auto Correction) in adol...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b0139095a17c711398f86d1cf4cb966
https://doi.org/10.1089/dia.2021.0319
https://doi.org/10.1089/dia.2021.0319
Autor:
Gregory P. Forlenza, Laya Ekhlaspour, Linda A. DiMeglio, Larry A. Fox, Henry Rodriguez, Dorothy I. Shulman, Kevin B. Kaiserman, David R. Liljenquist, John Shin, Scott W. Lee, Bruce A. Buckingham
Publikováno v:
Pediatric Diabetes. 23:324-329
Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical MiniMed™
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b614db1632625505ff7c58ddbd235f65
https://doi.org/10.1111/pedi.13312
https://doi.org/10.1111/pedi.13312
Autor:
BRUCE W. BODE, TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST, DOROTHY I. SHULMAN, ROBERT H. SLOVER, JOHN SHIN, FEN PENG, SUIYING HUANG, ANDREW S. RHINEHART, ROBERT A. VIGERSKY
Publikováno v:
Diabetes. 71
Objective: A CGM sensor that is disposable and requires no calibration may make glucose management easier for people living with diabetes. The present study reports on the interim analysis of a new disposable zero-calibration sensor in adults and you
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50a1dd55738f61d1c7db26b482f19a10
https://doi.org/10.2337/db22-672-p
https://doi.org/10.2337/db22-672-p
Autor:
ROBERT A. VIGERSKY, BRUCE W. BODE, RONALD L. BRAZG, BRUCE A. BUCKINGHAM, ANDERS L. CARLSON, KEVIN B. KAISERMAN, MARK KIPNES, DAVID R. LILJENQUIST, ATHENA PHILIS-TSIMIKAS, CATHERINE PIHOKER, RODICA POP-BUSUI, JOHN REED, JENNIFER SHERR, DOROTHY I. SHULMAN, ROBERT H. SLOVER, JAMES THRASHER, XIAOXIAO CHEN, MARGARET LIU, TONI L. CORDERO, MELISSA VELLA, ANDREW S. RHINEHART, JOHN SHIN
Publikováno v:
Diabetes. 71
Background: Safety and effectiveness outcomes of individuals using the MiniMed™ 780G system with the no-calibration Guardian™ 4 sensor during the first three months of use were analyzed. Methods: Participants (N=176, aged 7-75 years) with T1D use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ad1ab3c86af12c2910313a11fd45e99
https://doi.org/10.2337/db22-100-lb
https://doi.org/10.2337/db22-100-lb
Publikováno v:
Diabetes. 71
Background: TI is an inhaled mealtime insulin with ultra-rapid onset and short duration of action closely mimicking physiologic insulin. Clinical studies demonstrated a higher initial dose could result in faster titration to overcome a perceived lack
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c8f510f30c7e351c25be0d3a58b017
https://doi.org/10.2337/db22-1496-pub
https://doi.org/10.2337/db22-1496-pub
Autor:
Gregory P. Forlenza, Laya Ekhlaspour, Linda A. DiMeglio, Larry A. Fox, Henry Rodriguez, Dorothy I. Shulman, Kevin B. Kaiserman, David R. Liljenquist, John Shin, Scott W. Lee, Bruce A. Buckingham
Publikováno v:
Pediatric Diabetes. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b18d0f287709e66a9b0c7c51ec755949
https://doi.org/10.1111/pedi.13336
https://doi.org/10.1111/pedi.13336
Autor:
Gina Zhang, Barry Horowitz, Ronald L. Brazg, Anuj Bhargava, Satish K. Garg, Yogish C. Kudva, Suiying Huang, Robert Vigersky, Arvind Cavale, George Grunberger, Timothy S. Bailey, Sarnath Chattaraj, Bruce A. Buckingham, John Shin, Vivian Chen, Kevin B Kaiserman, James Thrasher
Publikováno v:
Diabetes. 70
Objective: Most insulin infusion sets (ISs) are labeled for 2- or 3-days use. The Medtronic EWIS is designed to increase wear time up to 7 days. This study reports on EWIS survival and performance during the pivotal trial (ClinicalTrials.gov: NCT0411
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d326dd40f23fa21e724e152827fad1c
https://doi.org/10.2337/db21-100-lb
https://doi.org/10.2337/db21-100-lb